 |
  |
||||||||
 |
|||||||||
|
|||||||||
 |
|||||||||
 |
|||||||||
|
|
 |
|
|
R & D |
|
|
|
Pipeline |
|
|
|
Vitrase® |
|
|
|
Istalol®
|
|
|
|
Xibrom™
|
|
|
|
Xibrom QD™ |
|
|
|
Ecabet Sodium |
|
|
|
T-Pred™ |
|
|
|
Bepotastine |
|
|
|
Strong Steroid |
|
|
|
|
 |
|||||||
|
|
|
|||||
|
|||||||
|
ISTA believes that productive research and development efforts are paramount to the success of any pharmaceutical company. As a result, the management team historically has chosen to invest more of its capital and other resources in the area of research and development than any other area of ISTA.
To read about the ISTA product pipeline, please click here. |
|||||||
|
|||||||
| © 2007 ISTA Pharmaceuticals. All Rights Reserved. Disclaimer | Privacy Policy |